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Edited by Francesc PosasAbstract Recent structural analyses support a model whereby
Mms2 interacts with and orientates Ub to promote Ubc13-med-
iated Lys63 chain formation. However, residues of the hMms2–
Ub interface have not been addressed. We found two hMms2
residues to be critical for binding and polyUb conjugation. Sur-
prisingly, while each single mutation reduces the binding aﬃnity,
the double mutation causes signiﬁcant reduction of Ub binding
and abolishes polyUb chain formation. Furthermore, the corre-
sponding yeast mms2 double mutant exhibited an additive pheno-
type that caused a complete loss of MMS2 function. Taken
together, this study identiﬁes key residues of the Mms2–Ub
interface and provides direct experimental evidence that Mms2
physical association with Ub is correlated with its ability to pro-
mote Lys63-linked Ub chain assembly.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Protein–protein interaction1. Introduction
Lys63-linked ubiquitin (Ub) chains are generated when the
C-terminus of one Ub is covalently linked to the Lys63 residue
of the next. In the last 10 years, a surge of research has pushed
these formerly ‘‘non-canonical’’ chains to the forefront of the
Ub ﬁeld. Some of the interest in Lys63-linked Ub chains is
attributed to an apparently distinct elongated poly-Ub struc-
ture that manifests a molecular signal that is likely independent
from proteasome-mediated degradation [1–4]. The list of path-
ways to which Lys63-linked Ub chains are now attributed is
steadily growing and includes those involved in immune-re-
sponse signaling [1,5,6], a cell-cycle checkpoint [7], apoptosis
[8], and DNA repair [5,9]. Rivaling interest in these signaling
functions is research aimed to determine the mechanism
behind Lys63-linked Ub chain synthesis that requires a unique
pairing between the Ub conjugating enzyme (E2) Ubc13, and
an E2-variant (UEV) that is homologous to E2s but lacks
the canonical active site for Ub thioester formation [10,11].*Corresponding author. Fax: +1 306 966 4311.
E-mail address: wei.xiao@usask.ca (W. Xiao).
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Saccharomyces cerevisiae, was originally isolated due to the
sensitivity of its mutant to DNA damage and was found to
be involved in the error-free branch of DNA postreplication
repair (PRR) [12]. Shortly thereafter, it was found that
Ubc13 is able to promote Lys63-linked Ub chains and that this
activity absolutely requires a UEV such as Mms2 [13]. These
ﬁndings were in accordance with the equivalent phenotypes
observed for mms2, ubc13, and ub-K63R mutants with respect
to PRR [13–15]. Mammals contain two UEVs, known as
Mms2 and Uev1 [10,11], that both are able to form stable com-
plex with Ubc13 but confer completely diﬀerent cellular func-
tions [5]. Biochemical studies showed that Mms2 can non-
covalently bind Ub and promote Lys63-linked Ub conjugation
upon heterodimer formation with Ubc13 [16].
Insight into the molecular mechanism of Lys63-linked Ub
chain formation became possible after the human [17] and
yeast [2] Ubc13-Mms2 heterodimer crystal structures were
solved. Nuclear magnetic resonance (NMR) chemical-shift
experiments were used to map interaction surfaces that were
applied to the 3-dimensional heterodimer structure in order
to create a computer-generated molecular model of the Ub-
Mms2-Ubc13-Ub tetramer [16,18,19]. The hypothetical model
revealed that Mms2 was likely to bind an ‘‘acceptor’’ Ub in an
orientation that presented the Ub-Lys63 residue in close prox-
imity to the C-terminus of a ‘‘donor’’ Ub bound to the Ubc13
active-site, thereby promoting a Lys63-speciﬁc Ub–Ub linkage
[18]. The accuracy of the model and the ensuing biological in-
sights have made this a gold standard in the ﬁeld of Ub conju-
gation.
Despite being a central requirement to the model of Lys63-
linked Ub conjugation, the physical interaction between Mms2
and Ub has not been suﬃciently addressed from a functional
standpoint which includes in vitro binding assays and in vivo
functional assays. First, the NMR and docking experiments
used to map the Mms2–Ub interaction surface were too gen-
eral to identify particular residues of importance. Second, the
analysis of speciﬁc Mms2–Ub interface residues in yeast was
performed without any relevance to physical interaction
[20,21]. With our recent publication of a high resolution
Mms2–Ub solution structure [22], we were able here to under-
take an appropriate structure-based approach toward mutat-
ing the Mms2–Ub interface. This analysis enabled the
identiﬁcation of speciﬁc Mms2 residues that directly aﬀect
physical interaction with Ub leading to a concomitant loss in
Ub conjugation function in vitro and biological function
in vivo.blished by Elsevier B.V. All rights reserved.
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2.1. Strains and cell culture
The S. cerevisiae two-hybrid strain used in this study is PJ69-4A
(MATa trp1-901 leu2-3, 112 ura3-52 his3-200 gal4Dgal80DPGAL2-
ADE2 LYS2::PGAL1-HIS3 met2::PGAL7-lacZ) and the assay was per-
form as described [23]. Functional complementation was performed
using the haploid S. cerevisiae strain HK580-10D (MATa ade-1
can1-100 his3-11,15 leu2-3, 112 trp1-1 ura3-1) as the wild-type. The
entire MMS2 open reading frame (ORF) was deleted by using an
mms2D::HIS3 cassette generated through PCR ampliﬁcation as previ-
ously described [14]. This mms2D strain was then used as the recipient
to delete the REV3 ORF using a rev3::hisG-URA3-hisG cassette that
was obtained by KpnI digestion of plasmid pDG347 [24].2.2. Recombinant protein expression and puriﬁcation
BL21(DE3)-RILcells (Stratagene) transformed with pGEX6-
hMMS2 or pGEX-hUBC13 [23] were used for the GST fusion protein
preparation [16]. Soluble extracts were passed through a prepacked
5-ml GSTrap column (Amersham Biosciences), which was then washed
with 5 column volumes of 1 · PBS. GST fusion proteins were eluted
with reduced glutathione elution buﬀer (10 mM glutathione in
50 mM Tris–HCl, pH 8.0) and dialyzed extensively against SPR buﬀer
(50 mM HEPES, 150 mM NaCl, 3 mM EDTA, and 0.005% surfactant
P20, pH 7.5). Protein concentrations were determined using the BCA
Protein Assay Kit (Pierce) as per the instruction manual.
Puriﬁed Ub was purchased from Sigma and suspended in the SPR
buﬀer before analysis.2.3. Site-directed mutagenesis
The site-directed mutagenesis of human MMS2 was performed
using a modiﬁed form of the megaprimer site-directed mutagenesis
approach [25] as previously described [23]. A similar strategy was used
to make site-speciﬁc mutations within the yeast MMS2 gene and
cloned into a single-copy plasmid YCplac111 [26] with its native pro-
moter and terminator sequences (YCpL-MMS2).2.4. Functional complementation in yeast
Gradient and dilution plate assays were performed as semi-quantita-
tive experiments to measure relative sensitivity to methyl methanesul-
fonate (MMS). S. cerevisiae HK580-10D mms2D rev3D cells were
transformed with YCpL-MMS2 derivatives and at least three individ-
ual transformants were examined. The gradient plate assay was
described previously [23]. For the serial dilution plates, 10 ll of over-
night cell culture grown in selective minimal media was spotted as
10-fold dilutions in water on selective minimal media agar plates con-
taining MMS. Plates were incubated at 30 C.2.5. Surface plasmon resonance (SPR)
SPR was performed using a Biacore X instrument. To create a chip
for protein interaction analysis, a research-grade CM5 sensor chip was
used to immobilize anti-GST antibody by amine coupling, according
to instructions in the Amine Coupling and GST Capture Kits (Bia-
core). Approximately 15000 response units (RU) of anti-GST anti-
body was immobilized to each of the two ﬂow cells (Fc1 and Fc2).
For all SPR experiments, GST fusion or native proteins were puriﬁed
to >95% homogeneity and dialyzed against SPR buﬀer. A ﬂow rate of
20 ll/min and a 2-min injection of 5 lg/ml protein was used to capture
1000 RU of the GST fusion protein (ligand) in Fc2. For a control,
puriﬁed recombinant GST was similarly injected into the other ﬂow
cell to capture 1000 RU in Fc1. All data generated were corrected
for background in real time (Fc2–Fc1). 10 ll of the Ub protein (ana-
lyte) at various concentrations was then applied to the ﬂow cells at
5 ll/min for 2 min to yield binding curves. Regeneration of the sensor
chip surface was accomplished with a 20 ll/min injection of 10 mM
glycine, pH 2.2, for 2 min. Biacore BiaEvaluations software was used
for curve ﬁtting using 1:1 molecular binding with mass transport for
determination of the binding constant. The computational data was
conﬁrmed through plots of the response at equilibrium (RU) versus
free analyte (nM) that were used to calculate the Kd, where Kd =
RUmax · slope in the double reciprocal plot (1/response versus 1/free
analyte) (data not shown).2.6. Ubiquitination assays
Ub conjugation assays were performed with a Ub thioester/initiation
conjugation kit purchased from Boston Biochem (Cat. # K-995) fol-
lowing the manufacturer’s instructions.
2.7. Structural imaging
The molecular image was generated using the protein data bank ﬁle
1ZGU and PyMOL version 0.96 by DeLano Scientiﬁc (www.pymol.
sourceforge.net).3. Results
3.1. The hMms2–Ub interface and selection of residues for
mutagenesis
The importance of the interaction between hMms2 and Ub
with respect to Lys63-linked Ub conjugation is underscored
by several detailed NMR studies we previously conducted to
identify hMms2 residues that undergo changes in chemical
shift upon interaction with Ub in vitro [16,18,19]. These stud-
ies provided a wealth of experimental data that was essential
for mapping the general surface of Mms2 involved in binding
Ub. However, these experiments identiﬁed an abundance of
Mms2 residues of putative importance. Therefore, it was not
until our recent report [22] of a high-resolution solution struc-
ture of hMms2 in complex with Ub that an appropriate struc-
ture-based approach to mutating the hMms2–Ub interface
could be taken.
The interface of the hMms2–Ub solution structure (Fig. 1) is
mainly comprised of packing between the single b-sheet faces
of hMms2 and Ub. Notably, Ub-Ile44 is centered upon
b-strands 1–3 of the hMms2 b-sheet. Ub-Ile44 is regarded as
the integral residue of the characteristic hydrophobic patch
that plays a predominant role in the interaction with various
Ub binding domains [27,28]. To determine whether Ub-Ile44
plays a similarly important role in binding to the Ub binding
domain of hMms2, we chose to mutate three hMms2 residues
that come into close contact with Ub-Ile44. As shown in the
hMms2-Ub structure in Fig. 1, the functional groups of
hMms2-Ser32, -Met49 and -Ile62 all pack against Ub-Ile44.
These residues represent each of the hMms2 b-strands at the
interface and each residue was also found to undergo chemical
shift changes upon binding Ub in in vitro NMR experiments
[18,19,22,29]. hMms2–Gln23, which does not visibly come into
contact with Ub-Ile44 but also undergoes a chemical shift
upon binding Ub, was also chosen in order to investigate a res-
idue of putative importance which lies at the periphery of the
hMms2–Ub interface. In order to simplify the interpretation of
data, all residues in question were mutated to alanine.
3.2. hMms2-I62A and -S32A are defective in binding Ub
Given that the physical interaction between hMms2 and Ub
is the basis for the model of Lys63-linked Ub conjugation by
Ubc13-hMms2, we sought a method to test a direct physical
interaction between hMms2 and Ub. Since the aﬃnity of
hMms2 for Ub was expected to be low based upon NMR
experiments [29], we ﬁrst employed the yeast two-hybrid assay
that we had previously used to detect a transient interaction
between Ubc13 and the E3 TRAF6 [30]. However, we were un-
able to observe an interaction between hMms2 and Ub (data
not shown) in our assays. The negative result was attributed
to detection limits, a possible impediment from the Gal4-
fusion with Ub, or an abundance of Ub-requiring pathways
Fig. 1. Solution structure of the hMms2–Ub heterodimer. Shown is an
NMR-derived molecular structure of a physical interaction between
hMms2 (blue) and Ub (yellow) based on the Protein Data Bank ﬁle
1ZGU. hMms2 residues that were identiﬁed through structural
analyses and mutated in this study are labeled and indicated with
stick and space-ﬁll representation. The Ub-Ile44 (stick and space-ﬁll,
yellow) residue is also shown. C- and N-termini for both proteins are
indicated with red and blue, respectively. The molecular structure was
generated with PyMOL v. 0.99.
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Fig. 2. Binding response of hMms2 mutant proteins to Ub in vitro.
SPR was used to measure the binding response at equilibrium of the
hMms2 mutant proteins with various concentrations of Ub. It is
notable that 5 mg/ml Ub yielded a maximum binding response for
wild-type (wt) Mms2 in these assays. Each data point is the average of
three independent experiments with error bars indicating the standard
deviations.
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Fig. 3. Ub conjugation activity of hMms2 mutants. The ability of
hMms2 proteins to promote Ub chain synthesis was tested in an
in vitro Ub conjugation assay using puriﬁed components. Reactions
contained E1, E2 (Ubc13, 0.4 mM), MgATP, Ub, and diﬀerent hMms2
proteins (0.4 mM) as indicated. A Western blot (WB) against Ub was
performed in order to detect di-Ub (Ub2) and tri-Ub (Ub3) chains in
the assay samples. A WB against hMms2 was performed on the assay
samples to help ensure that equal amounts of hMms2 proteins were
used. The background di-Ub has been previously observed even in the
absence of hUbc13 [23].
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To circumvent these issues, we used SPR as an in vitro ap-
proach to directly detect the hMms2–Ub physical interaction.
Puriﬁed GST-hMms2 was immobilized to an SPR sensor
chip and puriﬁed Ub was introduced as the soluble-phase ana-
lyte. This approach provided suﬃcient binding curves for the
wild-type hMms2–Ub interaction at a range of Ub concentra-
tions that enabled calculation of the Kd to be approximately
200 lM. The value is notably similar to the NMR-derived
Kd in another study [29], where the Kd was approximately
100 lM. The higher Kd observed in this study is likely due to
the GST-hMms2 fusion proteins used in our experiment.
Each of the mutated hMms2 proteins were then puriﬁed and
subjected to SPR analysis. Preliminary experimentation indi-
cated that hMms2-Q23A and -M49A substitutions have no
detectable decrease in binding to Ub (data not shown),
whereas the hMms2-I62A and -S32A mutants reduced the
binding response with Ub (Fig. 2). Over the range of Ub con-
centrations tested, hMms2-I62A led to relative Ub-binding re-
sponse that was reduced by up to one half, while hMms2-S32A
led to an up to fourfold reduction. To provide further insight
into the contribution of hMms2-Ile62 and -Ser32 to the
Mms2–Ub interface, a hMms2-S32A/I62A double mutant
was created and tested. Fig. 2 shows that an additive decrease
of up to tenfold in binding to Ub is caused by the combination
of the S32A and I62A mutations in a single protein. Through-
out these in vitro experiments, there were no expression or sol-
ubility problems with any of the hMms2 derivatives (Fig. 3),
suggesting that the proteins were properly folded. Further-more, each of the hMms2 mutants was similarly proﬁcient in
binding to Ubc13 during these SPR experiments (data not
shown).
3.3. Mms2-S32A/I62A is defective in Ub conjugation
It is strongly implied that the impaired in vitro binding
between mutant hMms2 and Ub results in compromised Ub
chain assembly. We sought to provide experimental support
for this notion through an in vitro Ub conjugation assay. As
seen in Fig. 3, in the presence of wild-type hMms2, hUbc13
readily formed di-Ub chains and a small amount of tri-Ub
chains. These chains have been previously determined to be
linked through Lys63 [16]. In the reaction containing
hMms2-I62A, formation of di-Ub chains was similar to wild-
type hMms2, but the level of tri-Ub chains was reduced. In
5346 L. Pastushok et al. / FEBS Letters 581 (2007) 5343–5348the hMms2-S32A single and hMms2-S32A/I62A double mu-
tants, di-Ub formation was not observed, which is consistent
with the hMms2–Ub binding experiment (Fig. 2). The back-
ground di-Ub formation in the absence of hMms2 or hUbc13
has been previously observed [16] and deemed to be non-spe-
ciﬁc. Hence, these results underscore that an hMms2–Ub phys-
ical interaction is absolutely required for the Ub conjugation
by the hMms2–Ubc13 E2 complex.
3.4. Yeast mutations corresponding to hMms2-I62A and -S32A
cause an additive defect in DNA postreplication repair
With the identiﬁcation of two hMms2 residues having phys-
ical importance to the Ub interface, we wished to determine a
possible correlation with their in vivo function. PRR in S. cere-
visiae is a powerful system for the phenotypic evaluation of
Mms2’s ability to conjugate Lys63-linked Ub chains, as we
previously demonstrated in a detailed structure-function anal-
ysis of the human Ubc13-Mms2 heterodimer formation using
this yeast system [23]. MMS2 and UBC13 can relieve cells
from DNA damage sensitivity through a PRR pathway that
is dependent on their synthesis of Lys63-linked Ub chains
[13]. In accordance, mms2D, ubc13D, and UB-K63R single,
double, and triple mutant strains have comparable sensitivities
to DNA damaging agents [13,15]. Therefore, the ability (or
lack thereof) of the Mms2 mutants to functionally complement
an mms2D strain in PRR should directly reﬂect their ability to
promote Lys63-linked Ub chain formation.
Amino acid sequence alignment (Fig. 4) indicates that both
Ser32 and Ile62 are conserved in budding yeast as Ser27 and
Ile57, respectively. In order to properly perform the functional
complementation experiments in yeast PRR, the correspond-
ing mutations in yeastMMS2 were created. This approach en-
abled the use of the chromosomal MMS2 gene with its own
ﬂanking sequences in a single copy plasmid. Moreover, it en-
sured that we were speciﬁcally testing the consequence of the
point mutations themselves, and not any other sequence vari-
ations between yeast and human Mms2.
To enhance detection sensitivity, MMS2 functional comple-
mentation after DNA damage was carried out in mms2 rev3
double-deletion strains. REV3 functions in a parallel branch
of PRR and shares a synergistic genetic relationship with
MMS2 [12,14]. It is therefore expected that defective MMS2
complementation in PRR would be most readily detected in
an mms2 rev3 double-deletion strain. In Fig. 5A, the mms2
rev3 double-deletion is extremely sensitive to the DNA damag-
ing agent MMS. However, this sensitivity is alleviated by theFig. 4. Mms2/UEV protein sequence alignment. Alignment of Mms2 protein
Residues identical to the hMms2 sequence are shaded black and residues corr
are indicated with ﬁlled circles. Hs, Homo sapiens; Sc, S. cerevisiae; Sp, Sch
melanogaster; At, Arabidopsis thaliana; Mm, Mus musculus.functional complementation of wild-type MMS2, which en-
ables the mms2 rev3D strain to grow on MMS to a level equiv-
alent to the rev3D single mutant. On the other hand, the
MMS2-S27A and -I57A mutations showed moderate pheno-
types as each single mutant was slightly more sensitive to
MMS than wild-type MMS2, reminiscent of the binding and
conjugation assays above. In contrast, the MMS2-S27A/
I57A mutant was extremely sensitive to MMS. To better relate
the phenotype of the double mutant, we retested the strains on
dilution plates with MMS concentrations that permitted
growth of the mms2 rev3mutant cells. As seen in Fig. 5B, while
using conditions where the MMS2 single substitution mutants
were only slightly sensitive to DNA damage, theMMS2-S27A/
I57A double mutant was severely sensitive to DNA damage. In
fact, the double mutant was as sensitive to DNA damage as the
cells with no source of MMS2 whatsoever (Fig. 5B).4. Discussion
The conjugation of Lys63-linked Ub chains by Ubc13 with
its cognate UEVs has become a topic of considerable interest
due to their aﬃliation with an increasing number of cellular
roles. Of particular importance is that they are associated with
pathways which govern human disease and cancer, such as im-
mune-response signaling [1,5,6], a cell-cycle checkpoint [7],
apoptosis [8], and DNA repair [5,9]. Although numerous struc-
tural studies have been undertaken to model the important
surfaces of Ubc13–UEV, this is the ﬁrst study to perform a
structure-function analysis of the mammalian UEV–Ub inter-
face.
This study employed a variety of approaches to address
quantitative aspect of UEV–Ub interaction and its eﬀects on
enzymatic activity and in vivo functions. These approaches
appear to diﬀer in resolution. For example, the yeast two-hy-
brid assay was unable to detect hMms2–Ub interaction,
whereas SPR appears to be much more sensitive. On the other
hand, the eﬀect of the hMms2-S32A mutation on the in vitro
Ub conjugation is much stronger than that of hMms2-I62A
and is indistinguishable from that of the double mutant,
whereas in the yeast-based in vivo functional analysis, both
MMS2-S27A and -I57A single mutants display visible but
moderate MMS sensitivity, while the corresponding double
mutant is completely defective. We suspect that parameters
contributing to the above variations include the sensitivity of
assays themselves, the threshold for the activity, as well assequences from various model organisms using the CLUSTAL method.
esponding to the hMms2–Ub interface that were mutated in this study
izosaccharomyces pombe; Ce, Caenorhabditis elegans; Dm, Drosophila
Yeast strain
wild-type
mms2Δ
rev3Δ
mms2Δ rev3Δ
YPD + 0.025% MMS        YPDTest DNA
None
Vector alone
MMS2
MMS2-S27A
MMS2-I57A
MMS2-S27A/I57A
Test DNA YPD + 0.01% MMS YPD + 0.015% MMS YPD
Vector alone
MMS2
MMS2-S27A
MMS2-I57A
MMS2-S27A/I57A
A
B
Fig. 5. Functional complementation of the yeast mms2 mutant in vivo. The in vivo function of mutated yeast MMS2 genes is examined by their
ability to protect an mms2D rev3D yeast strain from killing by MMS. (A) A gradient plate assay. Overnight cell cultures were printed on YPD plates
containing a gradient of 0.025%MMS, and cells that are better able to survive DNA damage grow farther along the gradient. Incubation was carried
out for 48 hours at 30 C. The arrow at the bottom of MMS-containing plate indicates an increasing MMS concentration. (B) A serial dilution assay
of mms2D rev3D transformants. Overnight cell cultures were spotted as 10-fold serial dilutions from left to right on selective minimal media that
contained either 0.01% or 0.015% MMS. Cells that are better able to survive DNA damage treatment grow at higher dilutions. Incubation was
carried out for 48 h at 30C. Test plasmids in both experiments were YCpL-MMS2 and its site-speciﬁc mutation derivatives as indicated.
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through this study a general order of UEV activity related to
the aﬃnity for Ub is clearly established, namely Wild-type >
I62A > S32A > I62A/S32A (corresponding to hMms2). Mean-
while, site-speciﬁc mutation of other hMms2 surface residues
thought to contact Ub does not appear to aﬀect its aﬃnity
for Ub to a detectable level. Consistent with this conclusion,
the residue corresponding to hMms2–Met49 is not conserved
in sequence alignments, while residues corresponding to
hMms2-Ser32 and -Ile62 are identical among UEVs in various
model organisms, except for a single conservative IleﬁMet
substitution in the fruit ﬂy UEV (Fig. 4).
In summary, among four hMms2 residues thought to inter-
act with Ub through previous structural analyses, our
combined approaches identiﬁed Ser32 and Ile62, as well as
the corresponding yeast residues, to play the major roles in
binding Ub and promoting Lys63-linked poly-Ub chains
in vitro and in vivo. More importantly, we demonstrated that
while mutations in each of the two residues compromised the
UEV activity, the simultaneous substitution of both resi-
dues resulted in essentially complete loss of the UEV activity
in vitro and in vivo. Our result is particularly important
because it suggests that the Ser32 and Ile62 residues at the
UEV interface provide a level of co-operation to physi-
cally interact with Ub. The multiple contacts made in
the UEV–Ub interface thus provide a greater degree of resil-
ience.While this study was in progress, studies on the yeast
Mms2–Ub interface were reported [20,21]. These studies exam-
ined the ability of mutated yMms2 in support of Ubc13-med-
iated di-Ub formation but not in vitro interaction between
Mms2 and Ub, which only provided inferences regarding the
physical interaction between yMms2 and Ub. In particular, a
recent study reported that single alanine substitutions of
yMms2–Ser27 and -Ile57 caused nearly a complete loss in
in vivo PRR functional complementation [20]. In contrast,
our study was guided by direct SPR physical interaction data
that allowed us to experimentally test for a correlation between
Mms2–Ub binding and function for both human and yeast
proteins. Indeed, we found that the hMms2-S32A and -I62A
point mutants that lowered binding to Ub in vitro also caused
an impaired ability for the corresponding yeast mutants to
function in PRR. Also, unlike the other report, we found that
each single amino acid substitution mutation only caused a
moderate decrease in the Mms2 activity, whereas the double-
substitution mutation caused a further reduction in binding
to Ub in vitro and a synergistic eﬀect on the in vivo MMS2
function. The exact diﬀerence in the two studies in the yeast
cells is unclear; however, we suspect that our employment of
the rev3D mutant background to enhance the mms2D pheno-
type and use of more sensitive assays such as the gradient plate
and serial dilutions may contribute to the additional important
observations. Hence, our experimental enhancement allowed
us to detect the additive/synergistic eﬀects of the two single
5348 L. Pastushok et al. / FEBS Letters 581 (2007) 5343–5348substitution that enabled the novel and reﬁned conclusions re-
ported in this communication.
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